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Structure-Function Studies of Epoxide Hydrolases. 
Abstract 
Epoxides are three-membered cyclic ethers formed in cells via several metabolic 
pathways. Epoxide hydrolases (EHs) are enzymes that hydrolyse epoxides to the 
corresponding diols.  
The main goal of this thesis was to investigate the structures of EHs from the 
/-hydrolase family.  
The first part concerns the structural and functional analysis of a protein-water 
channel found in EHs in many plants. Thermostability studies, sequence analysis 
and determination of the x-ray structure of a mutated EH enzyme from Solanum 
tuberosum led to the conclusions that the water channel in plants participates in 
stabilization of the protein structure and furthermore, it forms an efficient system to 
enable transfer of protons that are required for enzymatic catalysis.  
The second part describes how computational methods together with structural 
and kinetic information identified factors that are responsible for the enhanced 
enantioselectivity of an improved variant of EH from Aspergillus niger obtained 
during a directed evolution process. The x-ray structure of the mutant showed that 
dramatic changes in the active site explain why the preferred (S)-substrate binds 
more easily in the active site than the disfavored (R)-enantiomer. The study 
underscores the importance of obtaining structural data when attempting to 
understand the results of directed evolution. 
The last part presents the structures of two novel microbial EHs that have been 
shown to produce chemically valuable 1,2-diols and exhibit high enantioselectivity. 
Their similarity to the mammalian microsomal EH, a key enzyme in detoxification, 
provided new information about its possible structure. The improved sequence 
alignment based on the structural work gives new insights on the connections 
between sequences/structures and the broad scope of selectivities among EHs. 
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1  Background 
1.1  Introduction to the chiral world 
The French microbiologist Louis Pasteur (1822-1895) is most famous for his 
remarkable breakthroughs in the prevention of infectious diseases, but in his 
early work as a chemist, he also wrote a doctoral thesis on crystallography. 
He described there a phenomenon of the asymmetry of chemical 
compounds. Pasteur was the first one who found that some molecules exist 
in isoforms that are exact mirror images of each other. We call them chiral 
(, Greek), which means “hand” because like hands, they lack symmetry 
and therefore are not identical or superimposable (Fig. 1).  
 
  
Figure 1. Chirality of phenyl glycidyl ether (GPE).  
 
Since Pasteur’s discovery many other chemicals, particularly biologically 
active compounds, have been described as chiral. The essential building 
blocks of life, like amino acids or sugars, have been found to have isoforms 
called  enantiomers. This means that the resulting proteins, including cell   12 
receptors, hormones and enzymes, are also chiral, and what is even more 
important, they are enantioselective, i.e. they can distinguish between 
enantiomers of other chiral molecules. This in turn, has significant impact in 
the pharmacological industry because various drugs in their enantiomeric 
forms may be absorbed, activated or degraded differently. The enantiomers 
may have equal pharmacological activities, but more often only one is active 
whereas the others can be toxic or have negative side effects. Thence, it is of 
high importance to be able to distinguish and purify particular enantiomers 
from racemic mixtures. This means that pharmaceutical companies are 
always looking for easy and cheap ways of developing enantiomerically pure 
drugs. 
An enormous part of the chiral intermediate market relies on production 
of enantiopure epoxides and diols, which are key building blocks for the 
synthesis of a number of pharmaceutical compounds. For instance, various 
-adrenergic receptor agonists, anti-cancer agents, and anti-HIV drugs are 
synthesized from epoxide-containing substrates. Several chemical methods 
have been developed to prepare chiral epoxides and diols, but due to many 
obstacles such as low efficiency and enantioselectivity, they are not suitable 
for scaled up synthesis. That is why the general trend is moving towards 
biocatalysis that involves epoxide hydrolases - enzymes transforming 
epoxides to their corresponding diols.  
 
1.2  Epoxides  
Epoxides are organic three-membered heterocycles that contain polarized 
oxygen-carbon bonds. Epoxide (oxirane) rings are highly strained and 
unstable in a water environment, and exhibit nucleophilic activity that can 
cause irreversible toxic effects in reactions with such critical cell components 
as DNA, amino acids or purines. This in turn can lead to mutagenesis and 
carcinogenesis (Szeliga and Dipple 1998). 
Epoxides can be formed in cells via several metabolic pathways. 
Frequently they are generated by enzymatic oxidation of xenobiotic 
compounds, like during transformation of inhaled toxicants by cytochrome 
P-450 monooxygenase in human lungs (Hukkanen, Pelkonen et al. 2002). 
Another common route of epoxide formation is via endogenous metabolic 
pathways. For instance in plants, many epoxide-containing lipids take part in 
response to stress as wound-healing agents (Howe and Schilmiller 2002). 
They are also messengers in plant-pathogen interactions and precursors of 
cutin, which in turn serves as a protective barrier for plants (Pinot,   13 
Benveniste et al. 1999). In mammals, fatty acid epoxides are involved in 
blood vessel relaxation (Carroll, Schwartzman et al. 1987; Carroll and 
McGiff 2000) and inflammatory processes (Node, Huo et al. 1999; Kozak, 
Kluger et al. 2000).  
Very often epoxide-containing compounds play roles as signaling and 
regulatory molecules, but when not controlled, they may cause unnecessary 
chemical changes when reacting with other cell components. This makes 
the regulation of epoxide levels very critical, and so multiple systems have 
evolved in order to transform them into less active compounds.  
Two types of enzymes are responsible for the detoxification, of which 
one group is glutathione transferases, known as general detoxifying enzymes 
(Mannervik and Danielson 1988). By contrast, epoxide hydrolases (EHs) 
have been described as more specific for particular epoxide elimination 
(Seidegard and Ekstrom 1997). The latter enzymes, by opening the ring of 
epoxides, produce less active diols that show increased water solubility and 
therefore can be easily excreted (Fig. 2).  
 
Figure 2. Hydrolysis of an epoxide to the corresponding diol. 
1.3  Epoxide hydrolases 
EHs are ubiquitously found in nature and have been identified in many 
organisms including mammals, plants, insects and various microorganisms 
such as yeasts, filamentous fungi and bacteria. The functions of EHs vary in 
the different organisms, but the four main roles can be described as: 
detoxification (mostly in mammals), catabolism of specific carbon sources (in 
bacteria), response to stress (in plants) and regulation of signaling molecules 
(in mammals)  
Till now, several distinct sub-types of EHs have been described in pro- 
and eukaryotes. These include mammalian soluble epoxide hydrolase (sEH) 
and microsomal epoxide hydrolase (mEH), insect juvenile hormone EH, 
limonene-1,2-epoxide hydrolase (LEH), cholesterol 5,6-oxide hydrolase 
(ChEH), hepoxilin A3 hydrolase and zinc–metalloprotein leukotriene A4 
hydrolase (LTA4).  With the exceptions of last three, most of the epoxide   14 
hydrolases can be grouped into two main families. One is populated by EHs 
from microorganisms, with the LEH from Rhodococcus erythropolis as the 
archetype (Barbirato, Verdoes et al. 1998) and a recently discovered EH 
from Mycobacterium tuberculosis as a further example (Johansson, Unge et al. 
2005). The other family, formed by enzymes with an /-hydrolase fold, is 
larger and more diverse (Ollis, Cheah et al. 1992). Based on their subcellular 
localization and biochemical properties, enzymes within this family have 
been divided into two major groups, sEH and mEH, and both have their 
representatives in humans.  
 
All EHs that have been studied and are presented in this thesis are 
members of the /-hydrolase family and show sequence similarity to the 
human enzymes, sEH and mEH. This introduction will therefore 
concentrate on the /-hydrolase family members and will not discuss the 
other EHs that are not related in sequence and structure and thus have 
different catalytic mechanisms. 
 
1.3.1  Mammalian EHs – microsomal and soluble 
Of all known EHs, the first characterized was mammalian microsomal 
epoxide hydrolase (mEH), originally found in liver. It is an ~50kDa strongly 
hydrophobic protein, with a transmembrane anchor of 20 residues at the N-
terminal end. It has now been found in all evaluated mammalian tissues, 
with the highest activity in liver, testis, lungs and heart. Intracellularly, mEH 
is mostly attached to the smooth endoplasmic reticulum. The enzyme is 
very well known by pharmacologists and toxicologists because of its role in 
the metabolism of xenobiotic epoxide-containing compounds that might 
cause mutagenic and carcinogenic effects. It hydrolyses a number of 
environmental contaminants, like polyaromatic hydrocarbons, and drugs, 
e.g. 1,3-butadiene, phenytoin and benzopyrene. Despite the fact that mEH 
has been extensively investigated for decades, the x-ray structure remains 
unsolved, and because of the medical importance it is still urgently needed. 
The soluble epoxide hydrolase in mammals has been described as a 
homodimer with 62kDa subunits, where each subunit is build by two 
distinct functional domains having completely different structures (Gomez, 
Morisseau et al. 2004). The 35kDa C-terminal domain shows the epoxide 
hydrolase activity and has the /-hydrolase fold. The N-terminal domain is 
smaller, ~ 25kDa, shows phosphatase activity and has the topology typical 
for the haloacid dehalogenase superfamily. The activity of sEH has been 
found in all vertebrates inspected so far, including the teleost fish rainbow 
trout (Salmo gairdneri), mouse (Mus musculus), rat (Rattus norvegicus), rabbit   15 
(Oryctolagus cuniculus), domestic horse (Equus caballus), rhesus monkey 
(Macaca mulatto), and human (Homo sapiens). The distribution of sEH in 
tissues is very broad – from liver, kidney, lungs, heart, brain, spleen, 
adrenals, urinary bladder, to vascular endothelium, smooth muscles, skin, 
and leukocytes, but the highest specific activity has been reported in liver 
and kidneys (Pacifici, Temellini et al. 1988). Its critical role is in regulation 
of metabolic cascades influenced by epoxide-containing lipids. The best 
studied of the sEH substrates are epoxides of arachidonic acid 
(epoxyeicosatrienoic acids, EETs), that being a major component of the 
endothelium-derived hyperpolarizing factor, function as regulatory 
molecules in vascular, pulmonary and renal physiology.  
 
These two types of mammalian EH enzymes are distinguished not only 
by their subcellular localization, but also by different pH optima, physical 
properties and substrate specificity. In general, mEH hydrolyses mono- and 
cis-1,2-disubstituted epoxides, whereas the soluble enzyme prefers trans- 
over cis-epoxides (Ota and Hammock 1980) (Fig. 3).  
 
1.3.2  Plant EHs 
Soluble EHs have been isolated from different plants, such as soybean 
(Glycine max), mouse eared cress (Arabidopsis thaliana), potato (Solanum 
tuberosum), common tobacco (Nicotiana tabacum), oilseed rape (Brassica napus), 
spurge (Euphorbia lagascae), and lemon (Citrus jambhiri). The activity has been 
reported also in spinach (Spinacia olerecea) and apple (Malus pumila). EHs have 
been localized in many cell types including seedlings, germinated seeds, 
roots, fruit, tubers and leaves. They are located mostly in the cytosol, with a 
minor fraction associated with isolated microsomes (Blee and Schuber 
1992).  
The substrate specificity and regulation of transcription shows that the 
primary functions of this enzyme in plants lie in host defence and growth. 
Apart from the constitutive soluble EHs, there are also multiple inducible 
isoforms. The expression of these increases after exposure to hormones 
involved in growth, differentiation of meristematic tissues, germination, 
development, fruit ripening, and host-defence (Edqvist and Farbos 2003). 
Physical trauma in potato leaves (Stapleton, Beetham et al. 1994) or viral 
infection in the common tobacco have also been reported to increase the 
transcription of sEH (Guo, Durner et al. 1998). Moreover, plants produce 
massive amounts of epoxide-containing lipids that are used in cutin synthesis 
(Kolattukudy 2001) and the host defence response (Blee 2002) (Fig. 3).   16 
These kinds of lipids are the preferred endogenous substrates for plant 
soluble EHs, which by hydrolyzing them, play defensive roles in both active 
(production of anti-fungal acids) and passive (cutin biosynthesis) ways.  
 
Figure 3. Epoxides as substrates for different EHs a). trans-stilbene oxide, b). 8(9)-
epoxyeicosatrienoic acid, c). cis-stilbene oxide, d). octane 1,2-epoxide, e). butadiene 
monoxide, f). styrene 7,8-oxide, g). 9(10)-epoxy octadecanoid acid, h). glycidyl phenyl 
ether. 
 
1.3.3  Microbial EHs 
About 20% of the microorganisms with the whole genome sequence known 
possess putative EH genes (van Loo, Kingma et al. 2006). They have been 
identified in various bacteria, yeasts, and fungi (Archelas and Furstoss 2001), 
including A. radiobacter, A. niger, M. tuberculosis, B. megaterium, S. antibioticus, 
Pseudomonas spp., Corynobacterium spp., Norcardia spp., Arthrobacter spp., etc. 
Although the EHs have been intensively studied over the last few 
decades, the best characterized in terms of structure-activity properties are 
still those of mammalian origin. A relatively small number of EHs from 
microorganisms have been explored in detail and very little is known about   17 
their functions. However interest in microbial EHs has increased very 
recently, since several studies had shown that they catalyze the 
enantioselective conversion of industrially important epoxides and chiral 
diols, often showing high enantioselectivity and broad substrate scope.  
 
1.4  Structures and mechanism of EH 
The  /-hydrolase superfamily has one of the most frequently observed 
folds and includes not only EHs but also other hydrolases like lipases, 
esterases, haloalkane dehalogenases, carboxypeptidases, iminopeptidases and 
haloperoxidases. It is a diverse group of enzymes with very low sequence 
identities (often below 20%) and very different enzymatic functions. This 
superfamily is an example of divergent evolution that creates enzymes that 
come from a common ancestor and have the same fold, but different 
catalytic properties.  
To date, six structures of EHs belonging to the /-hydrolase family 
have been solved, including an enzyme from Agrobacterium radiobacter 
(AnEH) (Nardini, Ridder et al. 1999), sEH from Mus musculus (MmsEH) 
(Argiriadi, Morisseau et al. 2000), a fungal enzyme from Aspergillus niger 
(AnEH) (Zou, Hallberg et al. 2000), sEH from human (HssEH) (Gomez, 
Morisseau et al. 2004), a potato (Solanum tuberosum) EH (StEH1) (Mowbray, 
Elfstrom et al. 2006), and bacterial MtEH from Mycobacterium tuberculosis 
(Biswal, Morisseau et al. 2008). 
 Although these enzymes are different in sequence, their overall structure 
is highly conserved. They all consist of the /-hydrolase core domain, and 
a smaller lid domain (Fig. 4). The main domain is composed of a central 
twisted eight-stranded -sheet surrounded by -helices. The superposition 
of available EH structures shows that both -strands and -helices are well 
conserved within the main domain. The lid domain is built mostly by -
helices arranged in two layers. The first helix usually leads to the active site 
that lies in the cleft between the /-hydrolase domain and the lid. The 
next three helices of the lid form a nearly triangular arrangement over the 
active site, and are linked by a cap-loop to the last two helices, which in 
turn lie between the triangle and the /-hydrolase domain. The two 
domains are connected by loops I will call NL- and CL-loops (where L 
stands for the lid domain, while N and C stand for the N- and C-terminal 
part of the main domain, respectively). The length, fold and character of 
those three loops vary between different EHs and are thought to be 
connected with substrate specificity of particular enzymes.   18 
As mentioned before, EHs from the /-hydrolase family have been 
separated into two major groups, soluble (also referred to as cytosolic) and 
microsomal EHs. Most of the enzymes (mammalian and insect) from the 
latter one contain additionally an N-terminal membrane anchor. The 
microbial EHs from the same group lack the anchor and therefore are 
soluble, but still are ~70 residues longer than EHs from the cytosolic group. 
That is caused by the presence of an N-terminal meander that caps the lid 
domain  (Fig. 4). This meander forms a long hairpin-like structure with 
several -helices and interacts with both of the other domains, stabilizing 
dimer interactions. Most of reported EHs are in fact homodimers, with the 
exception of the plant enzymes, which have an additional loop in the lid 
domain, preventing dimerization. 
   19 
 
Figure 4. Overall structures of EHs from the /-hydrolase family. a) StEH1, b) AnEH, c). 
HssEH. For clarity, all enzymes are shown as monomers, but AnEH and HssEH are actually 
dimers. The core domains are colored in white and the lid domains in black. For AnEH, the 
N-terminal meander is shown in gray, while for HssEH this color indicates the additional N-
terminal domain displaying phosphatase activity. Catalytic residues as well as two tyrosines 
from the lid are shown in stick representations and colored as the domains from which they 
are originate.  
Despite a generally low sequence similarity, EHs possess a high conservation 
of the catalytic triad, which is composed of nucleophile-histidine-acid (Asp-
His-Asp/Glu). These residues are located in the main domain while two 
tyrosines, which are also involved in substrate binding, come from the lid.    20 
There are two main steps in the EH mechanism (Fig. 5). The first one is 
associated with the opening of the epoxide ring. The two tyrosines from the 
lid make hydrogen bonds with the oxygen of the substrate, while 
nucleophilic aspartate is attacking one of the epoxide-ring carbons. This 
results in the formation of a covalent alkyl-enzyme intermediate, which is 
subsequently hydrolysed by a water molecule in the second step of reaction. 
The catalytic histidine together with a second acidic residue (Asp or Glu) 
function as a charge-relay pair, which is responsible for water activation.  
 
 
Figure 5. Schematic view of epoxide hydrolysis catalyzed by epoxide hydrolase (in this case 
AnEH). Tyr314 and Tyr251 are responsible for initial binding and positioning of the 
substrate in the active site. In the first step of the enzymatic reaction, the unsubstituted 
carbon atom of the epoxide is attacked by the carboxylate sidechain of the nucleophilic 
Asp192. This opens the epoxide ring and the covalent alkylenzyme intermediate is formed. 
In the second step, a water molecule, previously activated by the His374/Asp348 charge 
relay, hydrolyses the intermediate and the diol is released as a product. Catalytic residues as 
well as two tyrosines from the lid are shown and labeled (AnEH numbering).  
The kinetic mechanism of EH in its simplest form is shown on Scheme 1, 
where Ks is the equilibrium dissociation constant of the substrate-enzyme 
complex (Michaelis complex), k2 is the rate of alkylenzyme intermediate 
formation, and k-2 and k3 are the rates of its hydrolysis, which in turn can 
lead either towards diol production or back into enzyme-substrate complex. 
The second step of the reaction in the majority of cases limits the rate of 
diol production (Widersten, Gurell et al. 2009).   21 
 
Scheme 1. Kinetic mechanism of EH. 
 
This mechanism applies to many reactions of epoxide-containing substrates 
(Tzeng, Laughlin et al. 1998) (Thomaeus, Carlsson et al. 2007). However, it 
does not take into account regiospecificity of the enzymes, i.e. which of the 
carbon atoms of the epoxide ring is attacked by the nucleophile, which in 
turn has important consequences for the stereochemistry of the final 
products of the reaction. It is noteworthy that since only one oxygen atom 
from a water molecule is incorporated into the product, the opening of the 
epoxide ring occurs in a trans-specific manner. Also, the configuration of the 
carbon atom that is attacked by the nucleophile can be either retained or 
inverted during the reaction, depending on the substitution pattern of the 
attacked carbon and the regioselectivity of the enzyme (Fig. 6).  
 
Figure 6. Stereochemistry of the reaction catalyzed by EH, illustrated for a chloro-substituted 
ethylene oxide. In the hydrolysis of a racemic mixture of epoxides, four hydrolytic pathways 
(k1-k4) are possible. Depending on the enantioselectivity of the enzyme, different 
enantiomers are hydrolyzed with different rates, whereas its regioselectivity determines which 
carbon will be attacked. In the majority of cases, the aspartate nucleophile attacks the less 
hindered carbon of the epoxide ring (k1>k2 and k4>k3).      23 
2  Current investigation 
 
2.1  Aim and scope of the thesis 
 
The work presented here describes the functional and structural studies of 
epoxide hydrolases from different organisms.  
The first part discusses the x-ray structure of an EH from a plant (S. 
tuberosum), analysis of which has led to the discovery of a protein-water 
channel leading from bulk solvent to the active site of the enzyme. Kinetics 
studies together with structural information from the mutated protein are 
presented here, giving new insights on how the enzyme works.  Moreover, 
sequence comparisons showed that this system is present also in other 
species, suggesting that plants might have evolved it for the reasons that are 
further discussed in paper I.  
The next chapter of the thesis describes results obtained in the directed 
evolution of EH from A. niger (paper II). Several computational methods 
were combined with enzyme kinetics and analysis of x-ray structures, which 
have led to the identification of factors that are responsible for the improved 
enantioselectivity of the enzyme. 
The last part of the thesis addresses the problem that inadequate structural 
information is available on epoxide hydrolases, particularly from the mEH 
branch. Paper III presents two structures of recently discovered proteins 
that are the most closely related to date to the human mEH, an enzyme that 
has been difficult to over-express and study. Its structure remains unknown, 
but because of mEH’s medical importance, there is an urgent need. The 
analysis of these structures provides new insights on the fold of mEH. Also, 
since the sequence identity within the EH superfamily is often very low, and 
at the same time this group of enzymes has a very wide spectrum of 
substrate specificities, the new structural results present exciting potential in 
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2.2  Proton wires in plant epoxide hydrolases (paper I) 
 
The soluble epoxide hydrolase from potato (StEH1) was first characterized 
in 2000 (Morisseau, Beetham et al. 2000). The x-ray crystal structure of 
wild-type enzyme was solved in 2006 (Mowbray, Elfstrom et al. 2006). The 
enzyme is a typical sEH with the common overall structure consisting of the 
core /-domain and the -helical lid domain. The active site is located 
between those two domains and five catalytic residues were easily identified 
by analogy with other EH structures.  
It has been shown that the pair of tyrosines from the lid (in this case 
Tyr154/Tyr235) is responsible for proper orientation of the epoxide in the 
active site by interacting with the epoxide oxygen. The hydrogen bonds 
with the phenol groups also stabilize the oxyanion that is formed during the 
first step of the enzymatic reaction, when the epoxide is attacked by the 
nucleophile Asp105. In the second step of the catalysis, the previously 
formed alkylenzyme intermediate is hydrolyzed by a water molecule 
activated by the general relay pair His300/Asp265. The first x-ray structure 
of StEH1 thus helped to understand the catalytic mechanism of the StEH1.  
Another interesting residue, Glu35, was later identified and proposed to 
be a linker in a chain of residues connecting the catalytic His300 with the 
solvent through hydrogen bonding (Thomaeus, Carlsson et al. 2007). While 
His300 activates the hydrolytic water molecule, Glu35 is responsible for its 
proper orientation before interacting with the alkylenzyme intermediate. It 
has also been proposed that the attack of the base-activated water molecule 
is simultaneous with protonation of the negatively charged intermediate, 
where the necessary proton is transferred from solvent through a chain of 
water molecules to the catalytic tyrosine, Tyr154. These water molecules 
are coordinated by several residues that are located in a tunnel leading from 
the protein surface to the interior of enzyme. This hydrogen bond network 
goes through the series Pro186-His269-Tyr249-Leu266-His153-Tyr154-
alkylenzyme-His300-Glu35-Ser39-Tyr219-Arg41-Glu215, where Pro186 
and Glu215 are situated at the protein/solvent interface, on two opposite 
entries of the tunnel (Fig. 7).   25 
 
Figure 7. Overall structure of StEH1, showing the proposed proton wire. The catalytic 
residues are shown in white, whereas residues involved in forming the putative proton wire 
are shown in black.  
Both the protein channel and the chain of water molecules were identified 
from the x-ray structure of wild-type StEH1. To understand the role of this 
putative network in catalysis, two single mutants, Y149F and H153F, and 
one double mutant, Y149F/H153F, were constructed, expressed and 
characterized by steady-state kinetic measurements and temperature 
inactivation studies. These particular mutations were chosen to disrupt the 
hydrogen bond network in the chain of waters and to understand the 
importance of the putative proton wire in the protonation step of the 
enzymatic catalysis. For better interpretation of the functional data, the x-ray 
structure of Y149F mutant was determined and compared to the wild-type 
structure.  
The protein was studied in collaboration with the Department of 
Biochemistry and Organic Chemistry at Uppsala University. The 
mutagenesis, protein expression, purification and characterization were 
performed by Ann Gurell and Mikael Widersten.  
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2.2.1  Protein crystallization and structure solution 
The first crystallization trials of the Y149F mutant were carried out directly 
after the last step of purification, performed on a HiPrep Sephacryl S-200 
(16/60) column equilibrated with 0.1 M sodium phosphate (pH 7.4). Many 
different crystallization conditions were tested, together with the previously 
used 25% PEG 10,000, 0.1 M HEPES, pH 7.5 (Mowbray, Elfstrom et al. 
2006) but no crystals ever appeared. Since the wild-type enzyme was 
successfully crystallized when the protein solution contained 30 mM Tris-
HCl, an additional step consisting of a quick buffer exchange on a PD10 
column was performed before setting up new crystallization experiments. 
With the new protein solution, crystals were easily obtained in the same 
conditions as for the wild-type StEH1 (Fig. 8).  
 
Figure 8. Crystals of the Y149F mutant of StEH1. 
The rod-like crystals (~0.1 x 0.05 x 1 mm
3) appeared within a couple of 
days, and a data set of 99.6% completeness to 2 Å resolution could be 
collected. The crystals possessed the symmetry of the space group P212121 
and the cell dimensions a=55.9; b=96.7; c=122.2 Å.  
 
2.2.2  Structural results 
The point mutation of Y149F caused only a few, very small changes in the 
structure. The overall fold remained the same, and superposition with the 
wild-type enzyme resulted in an r.m.s. difference of 0.2 Å when all C 
atoms were compared.  
Two molecules were found in the asymmetric unit, with an r.m.s. 
difference of 0.3 Å when all C
 atoms compared. In the active site of the A 
molecule, clear electron density compatible with a molecule of PEG was 
found. PEG is a known competitive inhibitor of mEH (Kerr, Rettie et al. 
1989) and in this case its binding is reasonable since it was present at 25% 
(w/v) in the crystallization conditions. The terminal part of the PEG lies   27 
close to the lid tyrosines, while the remainder of the visible density 
meanders out to the surface of the protein through a binding cavity. The 
inhibitor binds to the nucleophile Asp105 and to a water molecule that 
interacts with Tyr154 and Tyr235 (Fig. 9a). In molecule B, no additional 
electron density was observed; instead a water molecule was found at the 
same position as the terminal oxygen of PEG in molecule A (Fig. 9b). The 
binding modes of the PEG and water molecules are similar to those 
previously seen in the wild-type structure, and indicate the expected 
position of the oxygen in the epoxide ring of a potential substrate.  
 
 
Figure 9.  Active site of StEH1. The Y149F mutant is shown in the A (a) and B (b) molecules 
of asymmetric unit. Catalytic residues are labeled as well as the mutated residue 149 that faces 
out into the solvent (at left on both panels). The water molecules together with PEG bound 
to the tyrosines are shown. The hydrogen bonds are dashed. 
Replacing Tyr149 with a phenylalanine (i.e. removing an OH moiety) 
generated a space that in the mutated protein is filled by the closest water 
molecule coming from the solvent. The other water molecules of the 
putative wire remained in the same positions, coordinated by the same 
residues as in the wild-type enzyme (Fig. 10a-b).    28 
 
Figure 10. Comparison of proton wires in the active site of (a) wild-type StEH1 and (b) 
Y149F mutant. The catalytic residues as well as the ones involved in water coordination are 
labeled. The PEG molecule present in the wild-type structure is shown in a stick 
representation.   
2.2.3  Sequence comparisons 
A structure-based sequence alignment of epoxide hydrolases including 
sequences from other plants shows that the Tyr149 residue is present in 
eight out of the ten EHs that were compared (Fig. 11). This suggests that 
such highly conserved residue might be involved in coordination of water 
molecules in other plants. In contrast, the His153 residue found in StEH1 is 
otherwise present only in the EH of rice; other enzymes have a tyrosyl 
residue in that position. When modeled in StEH1, the hydroxyl group of 
this tyrosine replaces the histidine imidazole moiety in the hydrogen-
bonding chain. The other residues from the putative wire, like Pro186, 
Leu266 and His269, are also present in other sequences but their 
conservation is suggested reflect the need to maintain the correct local 
structure.  
It is noteworthy that the exit route of the enzyme channel formed by 
Glu35-Tyr219-Ser39-Arg41-Glu215 is structurally conserved in mammalian 
sEHs (Thomaeus, Carlsson et al. 2007), while the entry pathway built by 
Pro186-His269-Tyr149-Leu266-His153 could not be identified in any of 
the other available structures.    29 
 
Figure 11.  Sequence alignment of soluble epoxide hydrolases in plants. Arrows indicate 
residues participating in the putative proton wire; the catalytic residues are marked with stars. 
The lid domain is boxed and the secondary structural elements of StEH1 are shown.    30 
2.2.4  Functional studies 
Enzyme kinetics 
The enzyme activities with both enantiomers of trans-stilbene oxide (TSO) 
were determined by steady state kinetics studies for all three mutants. The 
results are listed in Table 1. 
Table 1. Steady-state kinetic parameters of TSO hydrolysis by wild-type and mutated StEH1. 



















Wild-type  23±2  10±1 2.4±0.2  3.8±0.1 4.7±0.5 0.80±0.07 
Y149F  44±2  36±3 1.2±0.06  6.8±0.4 6.8±0.9 1.04±0.09 
H153F  15±2  94±20  0.016±0.01  12±1 11±1 1.1±0.1 
Y149F/H153F  n.d.  n.d.   0.20±0.01 12±1  5.2±0.5  2.2±0.2 
 
In the reaction of Y149F mutant with R,R-TSO, both kcat and Km were 
higher when compared to the wild-type enzyme, which resulted in lower 
catalytic efficiency (kcat/KM). For the reaction with S,S-TSO, kcat and Km 
were only slightly increased, however, this did not affect kcat/Km.  
In the case of the H153F mutant, for the hydrolysis of R,R-TSO, kcat was 
not changed, while Km increased (9-fold), which resulted in a 15-fold drop 
in catalytic efficiency. With the S,S-enantiomer, both kcat and Km  were 
increased (2- and 3-fold), resulting in an unchanged kcat/Km. 
The difficulties in reaching enzyme saturation within the solubility range 
of the substrate meant that kcat and Km parameters could not be measured 
individually for the reaction of the double mutant (Y149F/H153F) with 
R,R-TSO as a substrate. However the catalytic efficiency could be 
measured, and decreased more than 10-fold compared to wild-type enzyme. 
When the S,S-enantiomer was used as a substrate, kcat increased, while Km 
remained unaffected, resulting in an increase of kcat/Km (2-fold).   
We interpret this to mean that, in the Y149F mutant, the additional 
water molecule filled the available space and joined the water chain, and 
that therefore the enzyme did not lose its catalytic activity. Nevertheless, the 
increase in kcat of the mutant when compared to the wild-type enzyme can 
not be caused by improved proton transport within the chain for two 
reasons: a) the rates of proton transfer between atoms are much faster than 
the catalytic turnover numbers, and b) it is not protonation of alkylenzyme   31 
that is the rate-limiting step but instead its hydrolysis (Thomaeus, Carlsson 
et al. 2007). 
 
Thermostability studies 
The catalytic activities of the wild-type enzyme and all three mutants 
(Y149F, H153F, and Y149F/H153F) were determined after incubation at 
55 °C. The wild-type enzyme exhibited the highest degree of resistance to 
the higher temperature, with a half-life of approximately 2.25 hours. The 
single mutants showed stabilities with intermediate half-lives, of one hour, 
whereas the double mutant exhibited the lowest stability with the shortest 
half-life (twenty minutes). The wild-type enzyme was also more resistant to 
thermal inactivation in higher temperatures. It retained 65% of its activity 
after 5 minutes incubation at 60 °C, whereas the Y149F mutant showed 
only 30% of its initial activity at 30 °C.   
The structure of Y149F mutant shows that even though the water chain 
is maintained, this mutation removes two hydrogen bond interactions 
involving protein residues, which might destabilize the structure. Removing 
the maximal number of interactions in the double mutant drastically lowers 
its half-life at higher temperature. The drop in stability should be interpreted 
as a time-dependent loss in catalytic activity rather than as a direct analysis of 
structural unfolding. The thermostability tests show clearly that all three 
mutations are responsible for loss of protein-water hydrogen bonding, 
which in turn destabilizes the mutant proteins. 
 
2.2.5  Conclusions 
Based on the thermostability data and conservation of most of the residues 
coordinating water molecules in the chain, two functions have been 
proposed for the water channel in StEH1. First of all, it can stabilize the 
enzyme structure via hydrogen bonds between water molecules and protein 
side chains. The second suggested role of this water-protein network is a 
function as a proton wire for efficient protonation of the alkylenzyme 
intermediate during catalysis. In the active site, the His300 imidazole must 
be unprotonated in order to function as a catalytic base, which results in an 
urgent need for an efficient proton transfer. On the other hand, the 
alkylenzyme intermediate requires protonation prior to its hydrolysis to 
form the final product. The analysis of the StEH1 structure suggests that 
plant epoxide hydrolases might have evolved an efficient system to supply   32 
and also remove protons from the active site by their continuous transport 
from the solvent to the buried active site and then again back to the solvent.  
 
2.3    Directed evolution of EH from Aspergillus niger (paper II) 
The recombinant epoxide hydrolase from A. niger ( AnEH) was first 
described in 1999 (Arand, Hemmer et al. 1999) and  the x-ray structure of 
the wild-type AnEH at 1.8 Å resolution was published a year later (Zou, 
Hallberg et al. 2000). Among other substrates, the enzyme is known as a 
catalyst in the hydrolysis of glycidyl phenyl ether (GPE). This compound 
has an aryl oxypropanolamine structure containing one chiral centre, 
characteristic for all glycidyl ethers that are important intermediates for the 
synthesis of -blockers, commonly used pharmaceutical drugs in 
hypertension treatment (Iakovou, Kazanis et al. 1999).  
The hydrolysis of GPE by AnEH is an example of a kinetic resolution 
where, one of the enantiomers from a racemic mixture is selectively 
degraded, leaving the other one behind (Fig. 12). In this type of reaction, 
the relative rate of the hydrolysis of two enantiomers is reflected by the 
enantioselectivity factor, E.  
 
Figure 12. Schematic representation of GPE hydrolysis catalysed by AnEH.  
The wild-type AnEH catalyzes this reaction with low enantioselectivity (E 
= 4.6), in slight favor of the (S)-diol. It has been shown previously that 
random mutagenesis of the enzyme could slightly increase the 
enantioselectivity factor (Reetz, Torre et al. 2004). That publication 
describes several dozen mutants that were created by using error-prone 
polymerase chain reaction (epPCR) and screened on the basis of their 
enantioselectivity. In this way, a new, improved variant of the AnEH had 
been discovered, displaying an E-value of 10.8, in favor of the (S)-diol.  
Based on previous experiments, the combinatorial active-site saturation 
test (CAST) was developed to perform mutagenesis of sites around the 
binding pocket of an enzyme. In this method a gene of a previously   33 
improved mutant is used as a template to perform random mutations at 
another site. The process can be repeated until the desired degree of catalyst 
improvement is achieved (Reetz, Wang et al. 2006).  
In our work, the previous x-ray structure was used to choose six 
different sites around the active site for the mutagenesis experiments. 
Screening of the mutants created led to the discovery of a highly 
enantioselective enzyme (with an E value of 193). Using kinetics, MD 
calculations, molecular modeling and X-ray structures we tried to analyze 
the factors responsible for the enhanced enantioselectivity of the mutant 
generated by directed evolution.  In addition, inhibition studies were 
performed on both mutated and wild-type enzyme, and the structure of the 
latter one in complex with an inhibitor were solved.  
Both wild-type and mutated enzyme were studied in collaboration with 
the Max-Planck Institute in Mulheim, and the Institute of Pharmacology 
and Toxicology in Zurich. Protein expression, purification and biochemical 
characterization were performed by A. Cronin and LW. Wang, while 
molecular dynamics simulations were done by M. Bocola and J. Sanchis.  
 
2.3.1  Protein crystallization and structure solution 
Crystals of wild-type AnEH were obtained by sitting drop vapor diffusion at 
room temperature, as follows: 2 μl of protein solution (17 mg/ml in 10 mM 
Tris-HCl, pH 7.4, 20 mM NaCl, 1 mM EDTA, and 0.02% sodium azide) 
were mixed with 2 μl of the reservoir (20% PEG6000, 0.1 M MES, pH 6.0, 
and 0.1 M unbuffered sodium acetate). Crystals (~0.3 x 0.4 x 0.02 mm
3) 
grew within one week and before flash-cooling, were soaked for 4 days in a 
cryoprotectant solution containing 20% PEG6000, 20% glycerol, 0.1 M 
MES, pH 6.0, and 0.1 M unbuffered sodium acetate, and 10 mM 
valpromide.  
The LW202 mutant protein was crystallized by vapour diffusion in 
hanging drops of protein solution (10 mg/ml in 10 mM Tris-HCl, pH 7.4, 
20 mM NaCl, 1 mM EDTA, and 0.02% sodium azide) mixed with 
reservoir solution (15% PEG 3350, 0.25 M ammonium formate) in 1:1 
ratio. Crystals (~0.3 x 0.4 x 0.8 mm3) appeared within 5 days. Before being 
flash-cooled in liquid nitrogen, crystals were transferred to cryoprotectant 
composed of 20% glycerol, 15% PEG 3350, and 0.25 M ammonium 
formate.  
For both structures, data were collected at the European Synchrotron 
Radiation Facility (ESRF), Grenoble. Diffraction data were indexed using 
MOSFLM (Leslie 1999) and processed with SCALA (Evans 1993) as   34 
implemented in the CCP4 interface (Potterton et al. 2003). The crystals 
possessed the symmetry of the space group P21. The protein model from the 
previously reported structure in the same space group (PDB (Berman et al. 
2000) entry code 1QO7 (Zou et al. 2000)) was used as the starting point for 
alternating cycles of rebuilding (Jones et al. 1991) and refinement 
(Murshudov et al. 1997). Two molecules were found in the asymmetric 
unit. The structures were refined by alternating cycles of refinement in 
REFMAC (Murshudov, Vagin et al. 1997) and model rebuilding in O 
(Jones, Zou et al. 1991). Statistics for data processing and the final model are 
reported in Table 2.  
Table 2. Data collection and refinement statistics. The space group in each case is P21. 




                                                 
a Calculated using a strict-boundary Ramachandran plot 
 
b Using the parameters of Engh and Huber.  
Data collection statistics  LW202 mutant  Wild-type in complex 
with valpromide 
Cell axial lengths (Å)  61.8, 89.7, 75.3  
(= 104.8°) 
63.0, 89.7, 75.8  
(= 105.3°) 
Resolution range (Å)  30.54 – 1.5  
(1.58 – 1.5) 
40.0 - 2.1  
(2.14 – 2.1) 
Average multiplicity  1.7 (1.7)  3.6 (2.7) 
Completeness (%)  95.5 (98.2)  99.5 (92.8) 
Rmeas (%)  2.7 (12.8)  6.6 (21.3) 
< <I>/<I> >  15.8 (7.2)  13.7 (4.3) 
Refinement statistics   
Resolution range (Å)  30.0 - 1.5  38.2 – 2.1 
R-value, Rfree (%)  18.3, 20.9  17.5, 22.1 
Mean B-factor, protein atoms, A and B 
molecules (Å
2) 
13.7, 13.9  13.6, 13.9 
Mean B-factor, solvent atoms (Å
2) 28.0  18.6 
Mean B-factor, valpromide atoms (Å
2)  - 17.6 
Mean B-factor, formic acid (Å
2)  11.4 - 
Ramachandran plot outliers (%)
a  1.6 1.5 
r.m.s. deviation from ideal bond length (Å)
b  0.01 0.01 
r.m.s. deviation from ideal bond angle (°)  1.01 1.19   35 
2.3.2  Structure of wild-type AnEH in complex with inhibitor 
The wild-type enzyme was soaked with its inhibitor 2-propylpentanamide 
(valpromide). This compound is commonly used as a drug in epilepsy 
treatment but is also known as a competitive inhibitor for the human liver 
mEH (Kerr, Rettie et al. 1989). It is been reported to inhibit other EHs, 
like the soluble EH from S. tuberosum (Mowbray, Elfstrom et al. 2006) and 
the unrelated limonene-1,2-epoxide hydrolase from R. erythropolis (Arand, 
Hallberg et al. 2003). In the AnEH case, the binding studies gave a 
measured Ki of 250 μM.  
The complex structure of AnEH with valpromide is very similar to that 
of the apo enzyme. The r.m.s. difference between these structures is 0.2 Å 
when all C atoms are included. The active site residues have the same 
positions, and the only residue within the binding-pocket that is different, is 
Leu349. Here, both main and side chains are moved, due to the 
accommodation of the inhibitor. The amide oxygen of valpromide forms 
strong, short hydrogen bonds to the lid tyrosines (Tyr251 and Tyr314), 
whereas the amide nitrogen is bound to the nucleophilic Asp192 and the 
main chain of the oxyanion hole residue Trp117 (Fig 13).  
 
Figure 13. Comparison of the active sites in the wild-type structure of AnEH with and 
without valpromide. The ligand-free enzyme is shown in gray, while the valpromide 
containing structure is colored black. Residues expected to participate in binding are labeled, 
together with the Leu349 that shows the largest movements in the active site. The hydrogen 
bonds between inhibitor and active-site residues are dashed. The ligand is shown in white.   36 
Previously, StEH1 was the only member of the /-hydrolase family that 
had been reported in complex with valpromide (Mowbray, Elfstrom et al. 
2006). this enzyme shares 19% amino acid sequence identity with AnEH, 
with an r.m.s. difference of 1.7 Å when all C
 atoms are compared. In both 
structures, the amide moiety of valpromide interacts with the nucleophilic 
aspartate, but the rest of the ligand is located in different positions in the 
binding pocket. The superposition based on the C
 positions on the five 
catalytic residues shows clearly differences in shapes of the active sites that 
explain the different positioning of bound inhibitor (Fig. 14a-b). The active 
site of StEH1 is very broad on both sides of the catalytic residues, which 
gives an extra cavity deeper inside the protein, in this case filled by the two 
aliphatic tails of valpromide (at left in panel a). In AnEH the binding pocket 
is much smaller and includes only the “outer” side of the catalytic triad (at 
right in both panels). This gives limited space for the inhibitor to bind in 
AnEH, especially due to the fact that the oxygen of the ligand amide binds 
strongly to the lid tyrosines. In StEH1, those two residues bind to a water 
molecule instead and valpromide is moved further into the “inner” cavity of 
the active site. In this structure the “outer” part of the pocket that leads to 
the solvent is occupied by a small fragment of PEG (Fig. 14a-b).    37 
 
Figure 14. Comparison of the active site cavities.  a) StEH1 with valpromide and a PEG 
molecule, b) AnEH wild-type in the complex with valpromide, c). apo AnEH wild-type, d). 
apo AnEH LW202 mutant. The catalytic triad (D192/105, H374/300 and D348/265) and 
the lid tyrosines (Y251/154 and Y314/235) are shown for AnEH/StEH1 and labeled. For 
the wild-type AnEH, the sites chosen for mutations are colored as follows: B (green), C 
(orange), D (magenta), E (red), and F (cyan) and correspond to the mutated residues in 
LW202.  
2.3.3  Structure of mutated enzyme 
The active site of AnEH lies between the /-hydrolase domain and the lid 
domain. A narrow hydrophobic tunnel leads to the active site, and the 
catalytic triad, as well as the two tyrosines sticking from the lid, are located 
in and around the tunnel. By modeling substrate (GPE) into that tunnel, six 
sites were chosen for mutagenesis experiments, named as A (composed by 
residues 193/195/196), B (215/217/219), C (329/330), D (349/350), E   38 
(317/319), and F (244/245/249) (see Fig. 1 in the paper). Several cycles of 
mutated protein were created and tested for their enantioselectivity, among 
which the highest E value (of 193) was found in the LW202 mutant, with 
nine mutations in total (in site B: L215F/A217N/R219S; site C: 
M329P/L330Y; site D: L249Y/C350V; site E: T317W; and site F: T318V) 
(Fig. 2 and 8a in the paper). 
The overall structure of the apo LW202 mutant is very similar to that of 
the apo wild-type AnEH (Fig. 15). The main domain has the classic /-
hydrolase fold, built two regions of residues 86-229 and 321-396. The lid 
domain is composed by six -helices, corresponding to residues 230-320. 
The first helix leads to the active site, which is located in the cleft between 
two domains. Helices 2-4 form a triangle over the active site, and are 
connected to the last two by a relatively short cap-loop (residues 284-291). 
Like in the wild-type AnEH, the last helix is disordered and the density for 
the following loop is also not visible (residues 320-327). The N-terminal 
region (residues 2-85) forms a curved meander that caps the lid domain; this 
type of feature is not found in enzymes like StEH1, and is more 
characteristic of the mEH family. The meander’s interactions with the 
helices of the lid domains from both molecules present in the asymmetric 
unit are thought to play a role in stabilizing the formation of dimers.  
 
Figure 15. Stereo view of overall structure of LW202 mutant (white) superimposed onto the 
wild-type AnEH (black). The C- and N-termini are labeled, and the catalytic residues are 
shown in stick representation.   
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Comparison of the two molecules in the asymmetric unit gives an  r.m.s. 
difference of 0.3 Å, when they are superimposed with all C
  atoms 
matching within a 2 Å cut-off. Due to crystal packing, two regions in 
molecule B (217-222 and around residue 356) are different when compared 
to molecule A. Molecule B has also an extra disordered loop (residues 222-
229) (Fig. 16). 
The 1.5 Å resolution of the data collected let us model multiple 
conformations for several residues in both molecules. Most of them are 
located in the N-terminal meander (residues 32, 36, 38, and 62) and in the 
loops pointing out to the solvent (e.g. 236, 253, 368, 383), but some of 
them were also found within the binding pocket.  
 
Figure 16. Superposition of two molecules present in the asymmetric unit of LW202 mutant 
(stereo view). The arrows point the the most striking differences that occur in the NL-loop 
region, residues 217-222 (at bottom left). Its C-terminal part is disordered in this molecule, 
but visible in molecule A (white). N- and C-termini are labeled.   
There are two active sites per dimer, each composed by residues from a 
single subunit. Asp192 is the catalytic nucleophile and His374/Asp348 form 
a general base-charge relay pair. This catalytic triad is located on the main 
/-hydrolase domain, whereas the two tyrosine residues Tyr251 and 
Tyr314 that are expected to assist the epoxide ring opening come from the 
lid. In both molecules, clear electron density for formic acid was observed. 
Since ammonium formate was present at 0.25 M in the mother liquor, its 
binding in the active site is reasonable. The ligand forms strong interactions 
with the nucleophile Asp192, as well as the two catalytic tyrosines (Fig. 
17a).   40 
Despite the fact that all catalytic residues are in the structurally conserved 
positions, the binding pocket is significantly different when compared to the 
wild-type  AnEH (Fig. 14c-d). The changes are mostly caused in a very 
direct way by the mutations that have been introduced. The “new” residues 
are not only different in size and character but also have a secondary effect 
on other residues. For instance, the side chain of Phe196 in the LW202 
mutant has a different conformation, pointing out from the active site. This 
conformational change is caused by the substitution at residue 317 of 
threonine with much bigger tryptophan. Within the active site, two residues 
show mobility and were modeled in multiple conformations (Ser195 and 
Val318) (Fig. 17a). 
 
Figure 17. The active site of AnEH. a) X-ray structure of the LW202 mutant. Electron 
density is shown for bound formic acid in the A molecule of the asymmetric unit, using a 
SIGMAA-weighted 2Fo-Fc map contoured at 1 =0.4 e/Å
3. The catalytic residues are 
labeled and the hydrogen interactions are dashed. Two residues with multiple conformations 
(S195 and V318) are also visible. b) Schematic view of the first step of hydrolysis.  The 
nucleophilic Asp192 attacks one of the epoxide carbons, while the oxygen from the substrate 
is bound to two tyrosines from the lid. The distance d is marked between the oxygen of 
Asp192 and one carbon of an epoxide. 
2.3.4  Molecular dynamics calculations 
As for StEH1, the hydrolysis of epoxides catalyzed by AnEH is believed to 
occur in two steps. First, two tyrosines (Tyr251 and Tyr314) bind and 
activate the substrate by forming hydrogen bonds to the oxygen atom of the 
epoxide, which is followed by an attack of Asp192 on the oxirane ring 
resulting in the formation of a covalent enzyme-substrate ester intermediate   41 
(Fig. 17b). In the second step, the intermediate is hydrolysed by the attack 
of a water molecule, previously activated through proton extraction using 
the His374/Asp348 charge relay.  
To study how the (R)- and (S)-substrates are positioned in the narrow 
binding pocket of AnEH, MD simulations were performed. Based on the 
apo wild-type structure of AnEH, a model of the enzyme harboring either 
(R)- or (S)-GPE was constructed with the additional assumption of two 
tyrosines binding to the oxygen of the substrate. Similar models were built 
for all intermediate AnEH mutants until the final LW202 mutant was 
reached. The same procedure was repeated for both enantiomers of the 
substrate as covalently bound to Asp192 in the form of an ester 
intermediate. The most significant finding is the correlation between the 
measured  E values for the particular mutants and the differences in the 
calculated distance from the MD experiments (d), described as a distance 
between the attacking oxygen atom of Asp192 and the epoxide carbon atom 
(Fig. 17b). For the wild-type enzyme, the d is expected to be 0.8 Å, with 
the preferred (S)-enantiomer slightly closer to the attacking aspartic acid. In 
the high enantioselective mutant LW202, the d increases to 1.6 Å (Fig. 
18). For the preferred (S)-substrate, the calculated distance does not change 
substantially, but the (R)-GPE is predicted to be positioned much further 
from Asp192 (d = 5.4 Å), which disfavors its ring-opening by nucleophilic 
attack (Table 3).  
In summary, the structural changes in the active site created by the 9 
mutations tend to disfavor binding of the (R)-enantiomer, making it more 
difficult for this enantiomer to be positioned within hydrogen bond-distance 
to the two tyrosines and at the same time to be close enough for the 
nucleophilic attack by Asp192.  
Table 3. Results of MD calculations. 
Mutations dR d S  dR-S  E  
Wild-type  4.3 3.5 0.8 4.6 
L215F/A217N/R219S  4.8 4.0 0.8 14 
As above plus M329P/L330Y  4.9  4.0  0.9  21 
As  above  plus  C350V 5.1 4.0 1.1 24 
As above plus L249Y  5.1  3.9  1.2  35 
LW202  5.4 3.8 1.6 115 
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Figure 18. Relation between differences in the calculated distance d from Asp192 to the C-
atom of epoxide and enantioselectivity (E) of the particular mutant.  
 
2.3.5  Docking experiments  
The predictions based on MD calculations agree with the x-ray structure 
obtained of the highly enantioselective mutant LW202. The automated 
docking studies on this particular protein were difficult due to the relatively 
high flexibility and several multiple conformations that were modeled 
during the structure refinement. Still some interpretations could be made 
based on a comparison of available structures of the wild-type and LW202. 
It becomes clear that upon the mutations, the active site shape and cavity 
change dramatically, especially around sites B and E (Fig 14c-d). Some of 
the differences are also due to the movement of Phe196 (part of site A, but 
not mutagenized in LW202). 
When the substrate is manually docked into the active site of LW202 in a 
manner that provides the optimal positioning with respect to the Asp192 
and two tyrosines, only the (S)-enantiomer fits easily, as it does in the wild-
type structure. In the case of the (R)-enantiomer, this binding mode places 
the epoxide ring in an unproductive orientation, away from Asp192. In 
addition, its phenyl moiety lies in an “aromatic box” formed by Phe215, 
Tyr249 and Trp317 that causes severe steric clashes (Fig. 19).  
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Figure 19. Active sites. a) The x-ray structure of the wild-type enzyme of AnEH. b) LW202 
mutant. The enantiomeric forms of GPE are manually docked and colored in white (S-GPE) 
and black (R-GPE). The catalytic Asp192, as well as the two tyrosines from the lid and three 
mutated residues, are labeled and shown in stick representation; interactions between 
tyrosines and epoxide oxygen atom are dashed. 
2.3.6  Inhibition studies on mutated enzyme 
Several efforts to soak crystals of mutated enzyme with valpromide were not 
successful; no electron density for the compound could be ever obtained. 
Later, the analysis of the apo structure of LW202 combined with inhibition 
studies revealed why this inhibitor could not be bound. Valpromide shows 
10-fold weaker binding to the mutated protein than to the wild-type 
enzyme (Kis of 2.5 mM and 0.25 mM, respectively). Also, the compound 
has two n-propyl groups (“arms”), which in a chiral environment like the 
active site of protein turn into diastereotopic groups (Fig 20a).  
 
Figure 20. Structure of EH inhibitors a) valpromide and b) valeramide.  
When compared to the substrate (GPE) used in the MD studies, the 
valpromide combines stereochemical features of both enantiomers in the   44 
sense that one arm corresponds to the CH2OPh moiety of the favored (S)-
GPE, and the other one to the placement of the CH2OPh in the disfavored 
(R)-GPE. Since the latter one is not accepted by the mutant in a manner 
that ensures hydrogen bonds to the lid tyrosines and nucleophile at the same 
time, binding one of the valpromide arms is also disfavored, which makes 
this compound a poor inhibitor.  
To confirm these ideas, another possible inhibitor was tested – 
valeramide (Fig 20b). This compound lacks one of the “arms” present in 
valpromide, which leaves the alkyl group free to rotate at the -carbon. 
There is no structure of AnEH with valeramide available, but we suspect 
that this kind of compound could easily suit the steric requirements in the 
chiral pocket of mutant enzyme. Based on the available structural data, 
valeramide is predicted to bind to the tyrosines (Tyr251 and Tyr314) and 
nucleophile Asp192 in analogous way to the favored substrate (S)-GPE. 
Kinetic studies in presence of (S)-GPE showed that valeramide is indeed a 
very efficient inhibitor, with Ki= 0.075 mM.  
 
2.3.7  Conclusions 
Based on kinetic studies, MD calculations, molecular modeling and x-ray 
structures, we analyzed the factors that are responsible for the increased 
enantioselectivity of a mutated variant of the AnEH enzyme previously 
generated by the process of directed evolution. The enhanced 
enantioselectivity in the production of (S)-diol was based on the model 
reaction of racemic glycidyl phenyl ether hydrolysis, and the selectivity 
factor of the mutant LW202 described here was increased over 25-fold in 
comparison to the wild-type enzyme (E=4.6). 
The molecular dynamics studies, together with analysis of structural data 
for the LW202 mutant, helped in the identification of the main reasons 
underlying this dramatic change in enzymatic behavior, showing that the 
preferred (S)-substrate binds easily in the binding pocket, whereas the (R)-
GPE encounters many steric clashes arising from the ways that the mutations 
change the shape of the active site. Some of the changes involve residues 
that were not mutated, and so would be very difficult to predict. 
This project shows the importance of obtaining x-ray structures in order 
to validate molecular modeling and computational calculations and help in 
the interpretations on a molecular level. The work described is also the first 
showing the structure of an enzyme with activity evolved by directed 
evolution methods.    45 
2.4  Introducing novel microbial epoxide hydrolases  (paper III) 
 
This project was carried out in collaboration with the Verenium 
Corporation (former Diversa), which is located in San Diego, California. 
The company constructed libraries of DNA isolated from a wide variety of 
microenvironments around the world. By using activity-based high-
throughput assays they discovered novel microbial EHs (about 50 in total). 
At the time when the project started, fewer than fifteen microbial epoxide 
hydrolases had been reported and very few of them carefully studied. All 
new proteins discovered by Verenium were found to be unique at the 
sequence level and have diverse substrate scope and enantioselectivity 
(Zhao, Han et al. 2004).  
The main goal of the project, from the company’s point of view, was to 
apply these enzymes to the synthesis of commercially important chiral 
diols/epoxides, since these are key intermediates for the biosynthesis of 
active pharmaceutical ingredients. On the other hand, the phylogenetic 
analysis showed that the new enzymes were highly diverse and represented a 
wide range of sequence space. Possible new structures could provide deeper 
insights into the general knowledge about EHs and help to understand the 
connection between their sequence/structure and substrate specificity. 
Therefore selected proteins were further characterized including x-ray 
structures determination and sequence analysis. 
 
2.4.1  Functional studies 
The newly discovered EHs have been screened with regard to their 
potential biocatalytic properties. In order to probe the functional diversity of 
these enzymes, several substrates representing both the terminal and internal, 
alkyl and aryl epoxides were used in screening. The studies showed that the 
set of enzymes exhibit broad substrate scope and novel activities. Active hits 
were found for every type of tested substrate, including those for which 
other known microbial epoxide hydrolases were ineffective (e. g. cis-stilbene 
oxide). In addition, many of these enzymes showed excellent 
enantioselectivity. For instance, desymmetrization of meso-epoxides was not 
effective by other known microbial EHs due to lack of activity or poor 
enantioselectivity (Fig. 21). Moreover, all previously reported EHs had been 
observed to predominantly form R,R-diols, whereas within the newly 
discovered EHs,  the first enzymes providing access to S,S-diols were found 
(Zhao, Han et al. 2004). Table 5 shows a few examples of the enzymes 
exhibiting the highest enantioselectivity using particular substrates.    46 
 
 
Figure 21.Desymmetrization of meso-epoxides carried out by the new microbial EHs.  
Table 5. Broad substrate scope of the newly discovered EHs.  
Epoxide-containing 
substrate 
Best hits for R-isomer  Best hits for S-isomer 









3-chlorostyrene oxide  BD8876  BD8877 
Epichlorohydrin BD7520  BD8877 
The results indicated the functional diversity of the discovered EHs and 
highlighted their potential use in many synthetic applications, such as the 
synthesis of key intermediates for the manufacture of important 
pharmaceuticals, including antibiotics, HIV protease inhibitors, anti-obesity 
and anti-depression drugs.  
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2.4.2  Protein purification, crystallization, and solving the structures 
Some of the best enzymes identified above (Table 5) were characterized 
further. The selected proteins (12 in total) were overexpressed in E. coli as 
constructs fused with a poly-His tag at C-terminus for purification on 
nickel-immobilized metal affinity columns. The purified enzymes were 
subjected to size exclusion chromatography. Because of very fast 
precipitation between subsequent steps of purification, some further 
optimization was needed, which is described in detail in Table 6.  
Table 6. Different approaches were tested in order to avoid protein precipitation during purification. n/e 
means “no effect”. 
Experiment Description  Effect 
Use of different buffers  Tris-HCl; sodium acetate; HEPES; 
CAPS 
n/e 
Try different pH of buffers  4.5; 7.5; 8.0; 9.0; 10.0  n/e 






Use of additives  L-arginine 50-400 [mM]  n/e 
 Glycerol  (10-30%)  n/e 
Use of detergents  Triton X-100 (0.5%)  n/e 
 Beta-octyl  glucoside  (0.5%)  n/e 
Reduce concentration of 
imidazole in elution buffer 
500 -> 200 [mM]  
n/e 
Change buffer immediately 
after affinity column 
purification 
Use PD10 column between affinity and 
gel filtration steps  n/e 
  Dialyse sample against gel filtration 
buffer without imidazole  n/e  
  Quick buffer exchange by several 
dilutions and concentrations on 
Centricon/Vivaspin 
No precipitation 
Work at 4 °C  From the cell harvesting to setting up 
crystallization drops  No precipitation 
Avoid freezing/thawing 
proteins 
Work with fresh batch of protein, or 
one stored at 4 °C 
No precipitation 
To summarize, the proteins tended to precipitate when purified at room 
temperature, or with a high concentration of imidazole present in the 
buffers. Another limitation was the fact, that the proteins could not be 
stored at -20 °C and again thawed. Taking this under consideration, to   48 
avoid precipitation all steps of purification (including cells harvesting, affinity 
chromatography, and gel filtration) in further experiments, were performed 
at 4 °C or directly on ice, when needed. In addition, in order to get rid of 
imidazole, the protein buffer after elution from affinity column was 
immediately exchanged by several dilutions and concentrations on 
Centricon/Vivaspin columns with appropriate size cut-off. Concentrated 
protein samples in 50 mM Tris-HCl pH 8.0, 200 mM NaCl, and 10 mM 
-ME were then applied to a size-exclusion chromatography column 
(Hiload
TM 16/60 Superdex
TM 200, Amersham Pharmacia Biotech). Eluted 
fractions containing significant amounts of the desired proteins as judged by 
SDS/PAGE analysis were concentrated to 20 mg/ml (A280,  = 2.0 ml mg
-
1·cm
-1) by using a Centriprep 10K concentrator (Millipore) and stored at 4 
°C. 
 
Six proteins of interest (out of 12) were purified and obtained in the soluble 
fraction. Consequently they were entered into the crystallization trials, by 
using vapor diffusion method (mostly sitting drops, consisting of fresh 
protein and reservoir solution in 1:1 ratio). Four of the proteins were found 
to crystallize easily in different kinds of crystallization solutions, but always 
containing PEG. They tended to form crystal clusters rather than single 
forms. Therefore in order to increase the size and quality of the crystals, 
microseeding was carried out (Bergfors 2003) (Fig. 22), where the initial 
crystal clusters were crushed and used as a stock to seed several drops that 
had been left to equilibrate for 1-5 hours. During the seeding experiments, 
the concentration of precipitant was gradually lowered to finally reach 18-
20% PEG, which was about 5-7% less than in the original drops where the 
crystal-clusters were found. After seeding, single crystals grew within 3-7 
days and were big enough for data collection, diffracting to approximately 
1.7 – 2 Å (for BD9883 and BD9300, respectively) and 2.5-3 Å (for BD8877 
and BD9884). 
 
Figure 22. Streak-seeding method. The initial crystal-cluster (at panel a) was used to streak-
seed the previously equilibrated drops (panels b-d). The characteristic streak-line, formed by 
micro-crystals is visible on panel b.   49 
The structures of two proteins were solved (BD9300 and BD9883), both by 
molecular replacement using either AMoRe (Navaza 2001) or Phaser 
(McCoy, Grosse-Kunstleve et al. 2005). Since the EH structure from A. 
niger (Zou, Hallberg et al. 2000) had the highest sequence similarity (35% in 
equivalent regions) to the BD9300, it was used as a search model. The 
sequence identity between BD9300 and BD9883 was 38%, which let us use 
the functional dimer of the former to solve the structure of the latter one.  
 
2.4.3  Structural results 
The overall structures of BD9300 and BD9883 are compared in Fig. 23a-b. 
As for other EHs of the microsomal class, they consist of three major parts: 
an N-terminal meander (residues 1-68/2-71 in BD9300/BD9883, 
respectively), a main /-hydrolase domain (two segments built by residues 
69-201/72–203 and 319-384/321-387), and a smaller lid domain (residues 
216-310/215-310).  
The long curved N-terminal meander has a hairpin-like structure built 
by several -helices. It interacts with the other two domains and is also 
partly responsible for dimer stabilization. The main domain has a classical 
/-hydrolase fold. The lid domain is mainly -helical and forms an insert 
in the main domain. These two domains are connected by the NL-loop 
(residues 202-215/204-214) and the CL-loop (residues 311-318/311-320) 
(Fig. 23c). 
The two molecules found in each asymmetric unit form a homodimer, 
stabilized by the interactions between the -helices of the lids and the N-
terminal meanders from both subunits. The helices of the lid domain are 
completely buried in the dimer interface, and these regions have the lowest 
temperature factors (~16 and ~10 Å
2, in BD9300 and BD9883). The central 
parts of the both domains are the most ordered while the loops show higher 
flexibility. Also, when the two structures are compared, the r.m.s differences 
are ~1.2 Å (with 3.5 Å cut-off); the C
 atoms that do not match are located 
in the NL- and CL-loops, and in the cap-loop. The NL-loop has the 
highest crystallographic temperature factors (~40 Å
2), and this region has also 
the weakest (although visible) electron density in both structures (Fig. 23d-
e).    50 
 
Figure 23. Overall structures. Comparison of a) BD9300 and b) BD9883. The N-terminal 
meander is shown in green, the main domain in blue and the lid domain in yellow. N- and 
C- termini are labeled. The NL-, CL- and cap-loops are colored in magenta, orange, and 
red, respectively Active site residues are shown in a stick representation. c) A topology 
diagram of BD9300 with the same color convention.  d) BD9300 and e) BD9883 colored by 
crystallographic temperature factors.    51 
The active sites of both proteins are located in the cleft between the two 
domains. The catalytic triad comes from the /-hydrolase domain. Of 
these, Asp176/179 (BD9300/BD9883) is the nucleophile, and His358 
together with Glu332 (His361/Asp334 in BD9883) function as the general 
base-charge relay. From the lid domain, a pair of tyrosines Tyr235/Tyr304 
in BD9300, and Tyr234/Tyr304 in BD9883 hydrogen bonds to the oxygen 
of the epoxide ring and are thought to assists in its opening.  
The active sites of the proteins are compared on Fig. 24. Electron density 
for PEG was observed in the active sites of both subunits in BD9883, 
modeled as tri- and di-ethylene glycol. The oxygen of its terminal hydroxyl 
group binds to the lid tyrosines, and one carboxylate oxygen of the 
nucleophile (Asp179) (Fig. 24a). The other carboxylate oxygen of Asp179 
interacts with the main-chain amide nitrogens of two nearby tryptophan 
residues (Trp103 and Trp180). The remainder of the visible PEG density 
extends out towards the solvent. 
 
 
Figure 24. Active sites. The active sites are shown for BD9883 and BD9300 in panels a and b, 
respectively. Side chains of the catalytic residues are shown and labeled. The active site water 
and PEG molecules are shown and helixes of the lid domain labeled as LA, LB and LF.  
The position of the terminal hydroxyl group of the PEG in BD9883 is 
occupied by a water molecule in BD9300 (Fig. 24b). Equivalent interactions 
are formed with the lid tyrosines, but the distance to the nucleophile 
Asp176 is larger (~4 Å). As in BD9883, Asp176 also binds to two 
tryptophan residues (Trp100 and Trp177), and lies near His358, which in 
turn hydrogen-bonds to its partner in the charge relay, Glu332 (which are 
equivalent to His361 and Asp334 in BD9883). 
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2.4.4  Structure vs. selectivity of EHs 
 
Structural comparisons with other enzymes from the /-hydrolase 
superfamily are summarized in Table 7. Only six epoxide hydrolases within 
this family are structurally available till date. Among those, the most closely 
related to either BD9300 or BD9883 is the fungal EH from A. niger 
(AnEH). The next structure is that of a bacterial EH from A. radiobacter 
(ArEH), with 22% sequence identity, although due to a possible error in 
part of this structure (involving the active site), it will not be discussed 
further. More distant are the EH from M. tuberculosis (MtEH), as well as the 
plant (StEH1) and mammalian soluble enzymes (HssEH and MmsEH).  
Among all available structures, the most similar part is within the /-
hydrolase domain. Both helices and strands are of more or less equal size and 
fold. The largest differences in this domain involve loops that fold out to the 
solvent. The lid domains, when compared, have only two residues truly 
conserved, both pointing into the active site and assisting the opening of a 
ring in the epoxide-containing substrate.  
The most striking differences in the lid are seen in the length and fold of 
the first (LA) and the last helix (LF). The first one is rather long in 
BD9300 and BD9883, as it is in AnEH, whereas other structures like 
mammalian EHs and StEH1 have very short LAs (6-8 residues comparing 
to 20 of BD9300). Usually this helix leads into the active site and is directly 
connected with LB, where one of the catalytic tyrosines is located. In the 
MtEH, the first helix of the lid is short, as is seen in HssEH, but here is 
followed by a long loop forming an extra sheet (not present in other 
structures) and it folds out toward the solvent rather than interacting with 
the second helix of the lid. The next three helices (LB – LE) are placed 
similarly and have approximately the same lengths in all structures. They 
form a triangle over the active site and are connected to the last two helices 
(LE and LF) by the cap-loop, which varies in length, and in some 
structures like BD9300/BD9883 and StEH1, also forms a short helix (~4 
residues) in the middle part. MtEH has the longest cap-loop (~67 residues), 
and although partially disordered, it forms an additional -helix and a small 
-sheet. The last helix of the lid (LF) is also very variable. In some 
structures it is relatively long (~20 residues), as seen in StEH1, HssEH or 
MtEH, but it also may be very short, like in ArEH (10) and MmsEH (7 
residues). In both our proteins, this helix is medium sized (13-14 residues).  
The lid domain forms an insertion in the main /-hydrolase domain 
and is connected to the latter by two loops (NL- and CL-loops). The 
manner in which the NL-loop folds, depends greatly on the nature of the   53 
first helix in the lid (LA). Since this helix is of similar size in both our 
proteins, as well as in AnEN, the intrinsic nature of the preceding NL-loop 
is analogous. Nevertheless, the positioning of the equivalent helices and 
loops in these structures differs a lot, which affects the volume of their 
active-sites (Fig 25). Since in BD9883 the NL-loop and following helix 
(LA) are positioned much closer to the last helix of the lid (LF), the 
t u n n e l  l e a d i n g  t o  t h e  a c t i v e  s i t e  p o c k e t  i s  m u c h  m o r e  n a r r o w  t h a n  i n  
BD9300 and AnEH (Fig. 26a-c). Both StEH1 and HssEH have relatively 
short NL-loops, which place LA on the opposite side of the active-site 
cavity compared to the other enzymes (much closer to LB and LF); the 
result is in each case a large difference in the entrance to the active site. In 
ArEH, the NL-loop and LA are disordered (residues 137-149), whereas in 
MtEH this loop has a completely different structure and topology, which 
results in a smaller opening leading from the solvent to the catalytic residues.  
The second loop, connecting the two domains, also varies a lot among 
the different EH structures. For instance, in StEH1, MtEH HssEH, the CL-
loop folds into a helix that is connected to LF by a kink (near Pro239 of 
StEH1). In AnEH this part of the structure is disordered (residues 319-329), 
and cannot be compared. In BD9883, the shift in the NL-loop (in 
comparison to corresponding fragment of BD9300) moves the CL-loop that 
brings it further outside the active-site cavity than its equivalent in BD9300 
(Fig. 25). 
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off (% id 
of 







BD9883    
AnEH  385  267 (33)  1.27  312 (36)  1.24  D192/H374/D348  1QO7 
ArEH  282  238 (21)  1.5  230 (23)  1.44  D107/H275/D246
a 1EHY 
MtEH  352  208 (19)  1.74  200 (18)  1.61  D104/H333/D302  2E3J 
StEH1  321  229 (15)  1.78  225 (21)  1.67  D105/H300/D265  2CJP 
HssEH 302
b  196 (18)  1.8  208 (19)  1.78  D333/H523/D495  1VJ5 
MmsEH 310




274  178 (16)  1.7  187 (15)
d 1.84  S94/H252/D223  1A8Q 
Hydroxynitrile lyase 
(Hevea brasiliensis) 





310  165 (17)  1.79  190 (14)  2.0  D124/H252/D223  2HAD 
Lipase (Candidia 
antarctica) 





313  146 (23)  1.86  146 (19)  1.85  S110/H294/D266  1AZW 
Chloroperoxidase L 
(Streptomyces lividans) 
275  195 (17)  1.86  200 (17)  1.9  S94/H253/D224  1A8S 
 
 
                                                 
a The third member of the active site triad is assigned by comparison with other 
sequences/structures. 
b Using only domain 2, residues 245-547. 
c Using only domain 2, residues 245-254. 
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Figure 25. The entry to the active site of superimposed BD9300, BD9883 and AnEH with 
valpromide bound (PDB entry code 3G0I). BD9300 is colored blue, BD9883 by white, and 




Figure 26. Comparison of the active site cavities. The active sites of BD9300, BD9883, 
AnEH, StEH1, HssEH, and MtEH are shown in the panels a-f, respectively. The views are 
the same, with the “outside” of the active sites (the one facing the solvent) to the right in 
each case. The catalytic residues are shown in stick representation and labeled.   56 
Structure comparisons among reported EHs show that the differences in 
the lid domain, as well as connected loops, definitely affect not only the 
shape, but also size and accessibility of the active site (Fig. 25 and 26). The 
question that remains unanswered is how those differences in size/shape of 
the cavities underlie the substrate specificities of particular enzymes. One 
could suspect that the enzymatic regioselectivity (i.e. preference for which 
of the carbons in the epoxide ring to attack) depends on the substrate’s 
placement in the active site. This in turn, dictates which particular diol is 
produced (see Fig. 6). 
  Also, if we compare the space in the active sites that is available for in-
coming substrates, it becomes clear that among available EH structures only 
in BD9300, BD9883 and AnEH is the “inside” part of the cavity not 
available (at left in Fig. 26a-c). This is mostly caused by a tryptophan residue 
that is located at the end of LD in these proteins and points into the active 
site (Trp268 in BD9300). In the rest of the enzymes, residues with smaller 
side chains replace the “big” tryptophan, at the same time leaving more 
space in the active site. This observation is correlated with the fact that 
highly substituted substrates have been shown to bind only to enzymes like 
StEH1. We predict that those EHs that lack tryptophan at this position will 
also have broader cavities in the binding pocket, and be able to accept more 
highly substituted substrates.  
 
Since only a few structures of EHs have been solved till now, the 
systematic analysis that could provide some “general” architecture allowing 
predictions of substrate specificity for new sequences was not possible. 
However some attempts of clustering EHs by their sequence alignments 
were done and published in 2004 (Barth, Fischer et al. 2004). At that time 
the only available structures were those of ArEH, AnEH and MmsEH. Based 
on this limited structure information and sequence alignments of other EHs, 
the authors divided EH sequences into three different clusters. The main 
criteria that were used here were based on the length and secondary 
structures of two loops, of which one is the defined earlier as the cap-loop, 
whereas the second, described by Barth et al. as NC-loop, covers the NL-
loop together with the first helix of the lid (LA). The authors have claimed 
that the clustering by loop length is highly correlated with substrate 
specificity and could help in structure modelling of new epoxide hydrolases.  
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Since then, the number of available structures has doubled and 
comparison of only BD9300, BD9883 and AnEH (Fig. 25) shows clearly 
that even if the length of NC-loops is similar, they can fold differently 
within the active site and its surroundings. Moreover, none of the cap-loops 
in either structure lies closely enough to the active site to affect its shape or 
determine the substrate specificity of the enzyme.  
When comparing the kinetic data that are available for these three 
proteins, it becomes clear that even quite similar enzymes (in terms of 
sequence, size of loops and overall fold) can have very different activities. 
For instance, the enzymes presented here are highly enantioselective towards 
the formation of R,R-diols from cis-stilbene oxide and cyclopentene oxide 
(Zhao, Han et al. 2004). In contrast, the most similar to them, AnEH as a 
wild-type, catalyzes the conversion of GPE with only slight favor towards its 
S-enantiomer, while the LW202 mutant (described in chapter 2.3) has this 
preference increased more than 100-fold (Reetz, Bocola et al. 2009).  
 
2.4.5  Sequence comparisons 
 
Sequence identity between available EH sequences is generally very low. 
The most conserved regions are within the main domain, which is reflected 
in the structure comparison. The variable size and fold of the lid domains as 
well as connected NL- and NC-loops are correlated with the fact that, 
within this region, only two active-site tyrosines are conserved.  
A structure-based sequence alignment, including EHs of known 
structures as well as the mEH, is shown in Fig. 27. The analysis of those 
sequences combined with the kinetic data could provide some suggestions 
in terms of predicting their activity. However, very often direct comparison 
of available data is impossible, since many studies published till now were 
designed differently and the enzymes were tested on various different 
compounds, often in the form of a racemic mixture. Based on the sequence 
alignment, similar to one shown in Fig. 27, but containing also other 
sequences of the most interesting enzymes presented here, a phylogenetic 
tree was constructed (Fig. 28). It reveals interesting trends regarding 
enzymatic activity where R,R- and S,S-diol producing enzymes seem to 
cluster together in the  sequence relationships. 
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Figure 27. Structure-based sequence alignment. The sequences were obtained from GenBank 
{Benson, 2003 #248} with accession numbers as follows: StEH1 (75102548), HssEH 
(27597073), ArEH (2292731), AnEH (6165234), MtEH (161760896), mEH (4503583). The 
first 233 residues of HssEH (the phosphatase domain) are omitted. Secondary structural 
elements of BD9300 were assigned with the structure in hand, while the various loops 
discussed in the text are marked as N and C, respectively, for the NL- and CL-loops. The lid 
domain is boxed, the catalytic residues are indicated by stars, and shading shows the sequence 
conservation. The tryptophan at the end of LD discussed in the text is indicated by an 
arrow, as well as the insertion within the NL-loop in mEH. 
   
Figure 28. Phylogenetic tree. The analysis is based on the sequence alignment described in 
text. The reported enantioselectivities in the production of R,R/S,S-diol product by the 
hydrolysis of meso-epoxides are shown in the parentheses. 
 
2.4.6  Shedding light on possible structure of human microsomal EH  
The organisms from which these two proteins originate are not known, but 
the sequence comparisons showed that they have the greatest similarity 
among all EH structures to the poorly understood microsomal branch of the 
EH family. This family includes mammalian microsomal EH (mEH), the 
structure of which still remains unavailable. Previously, AnEH has been the 
only structure representing this class of EHs. The sequences of all members 
of the mEH subfamily are on average 100-120 amino acids longer than most 
other EHs, mainly due to a hydrophobic N-terminal extension (shown in 
Fig. 27). The mammalian mEH was discovered decades ago, and since then   61 
many efforts have been made to purify and crystallize the enzyme, so far 
without success. Even when the N-terminal extension is removed form the 
constructs, the protein remains insoluble.  
Comparison of the sequences between our two proteins and human 
mEH provide deeper insights into a possible structure of the latter one. As 
seen in Fig. 27, mEH has an additional hydrophobic insertion, which in the 
s e q u e n c e  a l i g n m e n t  i s  l o c a t e d  i n  t h e  N L - l o o p  r e g i o n  ( o f  B D 9 3 0 0  o r  
BD9883).  Figure 24a shows clearly that this loop folds out from the main 
domain to the solvent and lies on the surface of the protein, at the entry to 
the active site. Considering the fact that mEH is associated mainly with the 
membranes, such an insertion could place this enzyme in an arrangement 
that makes it more effective in metabolizing the hydrophobic epoxides, 
among which many are the xenobiotic derived compounds. 
 
2.4.7  Conclusions 
The main goal of this project was a structural characterization of several 
epoxide hydrolases that had been recently discovered from microbial 
sources. Within this set of enzymes, many were found to exhibit high 
enantioselectivity levels and broad substrate scopes. The structures of two 
proteins have been solved and refined to high resolution. Both of them 
were previously shown to produce chemically valuable 1,2-diols and exhibit 
high enantioselectivity in reactions for which other known microbial EHs 
were not effective. Sequence analysis showed that these enzymes are also the 
most similar structures available to the mammalian microsomal EH, a key 
enzyme in degradation of xenobiotics. The structural investigation provided 
new ideas about this poorly understood but important enzyme. 
Furthermore, structural comparisons between these new structures and other 
EHs from the /-hydrolase family provided deeper insights on the 
connection between their sequence/structure and substrate specificity. Based 
on the structural work, we proposed an improved sequence alignment, 
showing that the differences in the lid, and the loops connecting it to the 
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All projects described in the thesis provided many new insights in the 
analysis of the epoxide hydrolases from the /-hydrolase family. Although 
these enzymes have been known for decades now, and much has been 
published about their general catalytic mechanism, the structural 
information still remains insufficient to allow detailed predictions of any 
kind concerning their enzymatic selectivity. Sequence comparisons can 
provide some suggestions, but because of generally very low levels of 
sequence identity (particularly in the lid domain and the loops connecting it 
to the /-hydrolase domain), there are still important gaps in the EH story 
that remain and should be addressed in future. The EHs presented here 
represent a collection of enzymes with various types of substrate scopes, 
activity and selectivity. The potential of such a library is enormous but more 
consistent kinetic studies together with systematic analysis on the sequence 
and structural level are still needed.  
To date, the EH from S. tuberosum (StEH1) is the only example of a 
structure of a predominantly S-selective enzyme. The sequence comparisons 
to other EHs from plants imply that they might prefer S-enantiomers as 
well, which suggests new candidates for further work.  
The mutated EH from A. niger (LW202) described here was the first 
reported structure of a mutated enzyme after successful directed evolution 
that had enhanced its enzymatic properties. The analysis of the x-ray 
structure was accompanied by MD calculations at all stages of evolutionary 
pathway. This project shows that combining computational methods with 
structural studies could help in the future in obtaining a better 
understanding of the catalytic mechanism of the proteins. The process of   64 
directed evolution could be productively applied in further experiments on 
some of newly discovered EHs isolated from environmental samples.  
Within this set of enzymes, the two new proteins that have their 
structure determined might help in solving the insolubility problem of 
microsomal EH from humans, which in turn could lead to solving the most 
desired structure among all EHs. This branch of the enzymes has the lowest 
sequence similarity, and therefore more structures of the microbial EH type 
are almost certainly needed.  
Furthermore, some of this family of enzymes show very interesting and 
novel enantio- and regioselectivities, like for instance BD9126, BD10721 
and BD10159, which preferentially produce S,S-diols in the 
desymmetrization of meso-epoxides. These proteins have been purified but 
never crystallized; solving those structures would be highly interesting and 
could give useful ideas on how the substrate is positioned in the binding 
pocket of EH. So far, the simple interpretations based on the shape of active 
site are not sufficient for a deeper understanding of detailed mechanism of 
EHs.  
Another interesting enzyme, which deserves further investigation, is 
BD8877, the most active in formation of R,R-diols from meso-epoxides 
(among reported EHs). The sequence comparisons suggest that the cavity of 
its active site might be broad enough to accept highly substituted epoxides, 
which to our knowledge was never tested but could give many interesting 
results.  
Finally, some of these proteins are possible candidates for trapping an 
alkylenzyme intermediate, which would provide many additional insights 
into the catalytic mechanism of those enzymes. Since it is the hydrolysis step 
that is generally thought to be rate limiting, trapping such an intermediate is 
in theory possible. To date, I have made many unsuccessful attempts at 
cocrystallizing and soaking the EHs crystals with epoxide-containing 
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